Bromisoval
Star1
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Bromisoval
- DrugBank Accession Number
- DB13370
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 223.07
Monoisotopic: 222.000391 - Chemical Formula
- C6H11BrN2O2
- Synonyms
- Bromisoval
- Bromisovalum
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your software1,2-Benzodiazepine The risk or severity of CNS depression can be increased when 1,2-Benzodiazepine is combined with Bromisoval. Acetazolamide The risk or severity of CNS depression can be increased when Acetazolamide is combined with Bromisoval. Acetophenazine The risk or severity of CNS depression can be increased when Acetophenazine is combined with Bromisoval. Agomelatine The risk or severity of CNS depression can be increased when Agomelatine is combined with Bromisoval. Alfentanil The risk or severity of CNS depression can be increased when Alfentanil is combined with Bromisoval. - Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- International/Other Brands
- Bromovalerylurea / Bromural / Brovarin
Categories
- ATC Codes
- N05CM03 — Bromisoval
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as carboximidic acids and derivatives. These are compounds containing a carboximidic group, with the general formula R-C(=NR1)OR2.
- Kingdom
- Organic compounds
- Super Class
- Organic acids and derivatives
- Class
- Carboximidic acids and derivatives
- Sub Class
- Not Available
- Direct Parent
- Carboximidic acids and derivatives
- Alternative Parents
- Propargyl-type 1,3-dipolar organic compounds / Organopnictogen compounds / Organooxygen compounds / Organobromides / Imines / Hydrocarbon derivatives / Alkyl bromides
- Substituents
- Aliphatic acyclic compound / Alkyl bromide / Alkyl halide / Carboximidic acid derivative / Hydrocarbon derivative / Imine / Organic 1,3-dipolar compound / Organic nitrogen compound / Organic oxygen compound / Organobromide
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- organobromine compound, N-acylurea (CHEBI:77043)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 469GW8R486
- CAS number
- 496-67-3
- InChI Key
- CMCCHHWTTBEZNM-UHFFFAOYSA-N
- InChI
- InChI=1S/C6H11BrN2O2/c1-3(2)4(7)5(10)9-6(8)11/h3-4H,1-2H3,(H3,8,9,10,11)
- IUPAC Name
- (2-bromo-3-methylbutanoyl)urea
- SMILES
- CC(C)C(Br)C(=O)NC(N)=O
References
- General References
- Not Available
- External Links
- KEGG Compound
- C12829
- ChemSpider
- 2353
- ChEBI
- 77043
- ChEMBL
- CHEMBL1515611
- Wikipedia
- Bromisoval
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 1.71 mg/mL ALOGPS logP 0.62 ALOGPS logP 0.8 Chemaxon logS -2.1 ALOGPS pKa (Strongest Acidic) 10.95 Chemaxon pKa (Strongest Basic) -7.7 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 72.19 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 43.93 m3·mol-1 Chemaxon Polarizability 17.9 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-001i-0910000000-c50e96d8fb27a437858f Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-006x-9130000000-3f0321ee2c0b1da7c12a Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-001i-5900000000-c7403b2001d04a97fd03 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-005c-9400000000-5f50097f18ab2fb18d23 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-0006-9000000000-bd363f017f5ebcb26064 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0536-5900000000-ddff87ab8c74aa4e67f0 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 134.61836 predictedDeepCCS 1.0 (2019) [M+H]+ 137.79211 predictedDeepCCS 1.0 (2019) [M+Na]+ 146.86868 predictedDeepCCS 1.0 (2019)
Drug created at June 23, 2017 20:40 / Updated at February 21, 2021 18:54